Post reply

The message has the following error or errors that must be corrected before continuing:: Warning: this topic has not been posted in for at least 120 days.
Unless you're sure you want to reply, please consider starting a new topic.

Name
Email
Subject
Message icon

Other options

Return to this topic
Don't use smileys

Verification:

Please leave this box empty:

Shortcuts: ALT+S post or ALT+P preview

Topic summary

Posted by Avram

- July 24, 2023, 14:03:11

Would this device be able to communicate with Omnipod? I currently use a Dexcom CGM that does that. Thanks.

Posted by Jon Lloyd

- July 24, 2023, 00:05:36

Lasting 14 days on a charge is fine but how long will it take to charge it? One hour would be much less concerning than, say, eight hours. The time it takes to charge can be quite dangerous to a brittle type 1 diabetic.

Posted by Tony

- July 23, 2023, 23:54:19

Why? Diabox does it already for free, real time from Libra or other one. no hardware needed.

Posted by Roberta Lipman

- July 23, 2023, 19:38:18

All fine and good but what if I don't want to use a smartwatch. Why can't it be a bracelet that you wear and then you have it connected to your smartphone. Q

Posted by Shady

- July 23, 2023, 18:58:59

It good 👍 to see technology improve our health monitor devices ,but we didn't see any thing about how it's works and how technological think just all things for markting

Posted by Anonymousgg

- July 23, 2023, 15:41:34

I am ready to welcome the clown car, and watch the diabeetus bots shamble out into the comment section.

Posted by Redaktion

- July 23, 2023, 06:48:02

The needle-free Glucowear continuous glucose monitor (CGM) has recently been exhibited at the American Diabetes Association's 83rd Scientific Sessions and has also had an impressive design overhaul. The non-invasive Glucowear blood sugar tracker could seriously disrupt the current diabetes device market if Afon manages to start selling it in 2024.

https://www.notebookcheck.net/Non-invasive-Glucowear-continuous-glucose-monitor-looks-set-to-be-diabetes-device-market-disruptor-as-Afon-sticks-to-2024-target.735766.0.html